Bradley, Alison <br/><br/>
Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis.  [electronic resource] 

 -  PloS one  2019 
 - e0212805 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0212805  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Clinical Decision-Making<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Decision Support Techniques<br/>Disease-Free Survival<br/>Humans<br/>Intention to Treat Analysis<br/>Markov Chains<br/>Neoadjuvant Therapy--methods<br/>Pancreatectomy<br/>Pancreatic Neoplasms--mortality<br/>Patient Selection<br/>Quality-Adjusted Life Years<br/>Randomized Controlled Trials as Topic<br/>Survival Analysis<br/>Time Factors